Reference (Feb-21-A8)
1. NCBI- (ncbi.nlm.nih.gov/pmc/articles/PMC7069463/)
Shetty AK. Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia. Aging Dis. 2020 Mar 9;11(2):462-464. DOI: 10.14336/AD.2020.0301. PMID: 32257554; PMCID: PMC7069463.
2. NCBI- ( ncbi.nlm.nih.gov/pmc/articles/PMC7069465/)
Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, et al. (2020). Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis, 11:216-228.
3. NCBI- ( ncbi.nlm.nih.gov/pmc/articles/PMC7167720/ )
Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Patho, 203:631-637.
